![]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/insights-hub-france/pharmabiotech/image_zeiss_arivis_pro.jpg/_jcr_content/renditions/original.image_file.100.67.150,0,1770,1080.file/image_zeiss_arivis_pro.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/insights-hub-france/pharmabiotech/image_zeiss_arivis_pro.jpg/_jcr_content/renditions/original.image_file.360.240.150,0,1770,1080.file/image_zeiss_arivis_pro.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/insights-hub-france/pharmabiotech/image_zeiss_arivis_pro.jpg/_jcr_content/renditions/original.image_file.768.512.150,0,1770,1080.file/image_zeiss_arivis_pro.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/insights-hub-france/pharmabiotech/image_zeiss_arivis_pro.jpg/_jcr_content/renditions/original.image_file.1024.683.150,0,1770,1080.file/image_zeiss_arivis_pro.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/insights-hub-france/pharmabiotech/image_zeiss_arivis_pro.jpg/_jcr_content/renditions/original.image_file.1280.853.150,0,1770,1080.file/image_zeiss_arivis_pro.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/insights-hub-france/pharmabiotech/image_zeiss_arivis_pro.jpg/_jcr_content/renditions/original.image_file.1440.960.150,0,1770,1080.file/image_zeiss_arivis_pro.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/insights-hub-france/pharmabiotech/image_zeiss_arivis_pro.jpg/_jcr_content/renditions/original.image_file.1620.1080.150,0,1770,1080.file/image_zeiss_arivis_pro.jpg"})
Empowering Biotech and Pharma Innovation
An Introduction to 3D High Content AnalysisTuesday, July 15th | 9:30 AM - 10:30 AM CEST
Webinar Information
Join us for an introduction and learn how 3D High Content Analysis Solutions are advancing innovation in biotech and pharmaceutical research. This webinar will explore how automated imaging workflows simplify the acquisition of high-quality, reproducible 3D images - scaling from single experiments to high-throughput screening with ease.
Discover how ZEISS solutions seamlessly integrate AI-based segmentation tools to deliver accurate, robust insights from complex 3D biological samples. Discover how these technologies enable researchers to accelerate discovery, reduce manual variability, and gain deeper, data-driven insights into cellular processes.
Whether you're working in drug development, disease modeling, or phenotypic screening, this session will demonstrate how our cutting-edge solutions can elevate your imaging workflows to meet today’s demands for speed, precision, and scalability.
Webinar Highlights
- Learn how ZEISS 3D High Content Solutions automate workflows for high-quality images and scalable results.
- Discover how automated solutions make high-quality image acquisition effortless and precise
- Gain insights into how AI segmentation tools are implemented in 3D High Content Workflows to enable robust and accurate 3D results
![]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/authors/molly-mcquillken.jpg/_jcr_content/renditions/original.image_file.100.100.1,0,1232,1231.file/molly-mcquillken.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/authors/molly-mcquillken.jpg/_jcr_content/renditions/original.image_file.360.360.1,0,1232,1231.file/molly-mcquillken.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/authors/molly-mcquillken.jpg/_jcr_content/renditions/original.image_file.768.768.1,0,1232,1231.file/molly-mcquillken.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/authors/molly-mcquillken.jpg/_jcr_content/renditions/original.image_file.1024.1024.1,0,1232,1231.file/molly-mcquillken.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/authors/molly-mcquillken.jpg/_jcr_content/renditions/original.image_file.1231.1231.1,0,1232,1231.file/molly-mcquillken.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/authors/molly-mcquillken.jpg/_jcr_content/renditions/original.image_file.1231.1231.1,0,1232,1231.file/molly-mcquillken.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/resource-center/insights-hub/authors/molly-mcquillken.jpg/_jcr_content/renditions/original.image_file.1231.1231.1,0,1232,1231.file/molly-mcquillken.jpg"})
Molly McQuilken, is a business development manager for ZEISS. Molly began her career with ZEISS specifically focused on the shaping the ZEISS arivis image analysis platform for biotech and pharma, but has since expanded her focus to full imaging solutions. Before starting her career with ZEISS arivis in 2017, she completed her PhD where she supported the development two new microscopy techniques and of an open-source image analysis toolkit. This experience developing an end-to-end workflow for other microscopists during her PhD, allows her to intuitively understand customer imaging challenges and identify areas where ZEISS can develop solutions to support researchers now and for the long-term.